Martin Quibell Email and Phone Number
Medicinal Chemistry Lead
at
Grey Wolf Therapeutics
Martin Quibell's email is mquibell@shire.com
.
Martin Quibell Contact Details
Email
mquibell@shire.com
Martin Quibell Company Details
Company
Location
Oxford, Oxfordshire, United Kingdom
Website
Industry
Biotechnology
Martin Quibell's Current Company
Grey Wolf Therapeutics
Industry | Biotechnology | |
Location | Oxford, Oxfordshire, United Kingdom |
Industry | Biotechnology | |
Location | Oxford, Oxfordshire, United Kingdom |
Martin Quibell's Experience and Education
Amura Therapeutics
Chief Scientific Officer
2000-09 to 2010-06
Peptide Therapeutics
Head Of Combinatorial Chemistry Then Director Of Medicinal Chemistry
1996-02 to 2000-08
Research Scientist
1991-10 to 1996-02
London, Greater London, United Kingdom
Belfry Therapeutics
Co Founder And Director
2016-11 to Unknown
Medicinal Chemistry Lead
2018-04 to Unknown
Oxford, Oxfordshire, United Kingdom
Maqu Chemistry Consulting
Director
2014-03 to Unknown
Pedanius Therapeutics
Founder And Director
2018-05 to Unknown
Frequently Asked Questions about Martin Quibell
What company does Martin Quibell work for?
Martin Quibell works for Grey Wolf Therapeutics
What is Martin Quibell's role in his workplace?
Martin Quibell's role in his workplace is
Medicinal Chemistry Lead .
Which industry does Martin Quibell work in currently?
Martin Quibell works in the industry
Biotechnology.
What is Martin Quibell's email address?
Martin Quibell's email address is mquibell@shire.com
What schools did Martin Quibell attended?
Martin Quibell attended
University Of Birmingham.
Who are Martin Quibell's colleagues?
Martin Quibell's colleagues are
Michael Pinggera,
Valeriya S,
Peter Joyce,
Wayne Paes,
Jessica Sette,
Kate Anderton,
Michael Pinggera,
Wayne Paes,
Peter Joyce,
Valeriya S,
Jessica Sette,
and
Kate Anderton.
Who are Martin Quibell's peers at other companies?
Martin Quibell's peers at other companies are
Jennifer Davoren,
Tim Scott,
Jose Torello,
Tin Kelly,
Ryan Newell,
Hein Mück,
and
Jason Hickman.